Welcome to My Site

If this is your first visit, welcome! This site is devoted to my life experiences as a Filipino-American who immigrated from the Philippines to the United States in 1960. I came to the US as a graduate student when I was 26 years old. I am now in my mid-80's and thanks God for his blessings, I have four successful and professional children and six grandchildren here in the US. My wife and I had been enjoying the snow bird lifestyle between US and Philippines after my retirement from USFDA in 2002. Macrine(RIP),Me and my oldest son are the Intellectual migrants. Were were born in the Philippines, came to the US in 1960 and later became US citizens in 1972. Some of the photos and videos in this site, I do not own. However, I have no intention on infringing on your copyrights. Cheers!

Thursday, January 23, 2025

Artificial Intelligence in Drug Discovery and Development

During one of our meal time conversations here at THD, a new resident asked me what I did prior to my retirement. I told her that prior to my retirement I was a Chemistry Team Leader in the Division of Anti-Infective Drugs Products, Centers New Drugs, Food and Drug Administration (FDA). Thus, I was involved with approval of new drugs and its development, primarily the Chemistry, Manufacturing and Control ( CMC) part of the development. https://chateaudumer.blogspot.com/2017/03/chemistry-manufacturing-and-controls.html

This smart newcomer then asked me what I know about AI ( Artifcial Intelligence) on drug discovery and Development. 

My answer was NOTHING or NADA.  Thus, this posting on my current google search on the subject.

Artificial Intelligence (AI) has recently started to gear-up its application in various sectors of the society with the pharmaceutical industry as a front-runner beneficiary. This review highlights the impactful use of AI in diverse areas of the pharmaceutical sectors viz., drug discovery and development, drug repurposing, improving pharmaceutical productivity, clinical trials, etc. to name a few, thus reducing the human workload as well as achieving targets in a short period. Crosstalk on the tools and techniques utilized in enforcing AI, ongoing challenges, and ways to overcome them, along with the future of AI in the pharmaceutical industry, is also discussed. The article below highlights the following:

  • 1. Artificial Intelligence (AI) has revolutionized many aspects of the pharmaceuticals.


  • 2. AI assistance to pharma industries helps to improve overall life cycle of product.


  • 3. AI can be implemented in pharma ranging from drug discovery to product management.


  • 4. Future challenges related to AI and their respective solutions have been expounded.

Conclusion: The advancement of AI, along with its remarkable tools, continuously aims to reduce challenges faced by pharmaceutical companies, impacting the drug development process along with the overall lifecycle of the product, which could explain the increase in the number of start-ups in this sector.  The current healthcare sector is facing several complex challenges, such as the increased cost of drugs and therapies, and society needs specific significant changes in this area. 

With the inclusion of AI in the manufacturing of pharmaceutical products, personalized medications with the desired dose, release parameters, and other required aspects can be manufactured according to individual patient need . 

Using the latest AI-based technologies will not only speed up the time needed for the products to come to the market, but will also improve the quality of products and the overall safety of the production process, and provide better utilization of available resources along with being cost-effective, thereby increasing the importance of automation.

For Complete Details visit: https://pmc.ncbi.nlm.nih.gov/articles/PMC7577280/

Meanwhile,  here are the real luxuries in life, we all should aim for in our aging years.


And Lastly, My Food for Thought for Today


1 comment:

Anonymous said...

Excellent! Shari Redka

Related Posts Plugin for WordPress, Blogger...